Clinical Trials Logo

Clinical Trial Summary

Hydrosalpinx (HX) has a detrimental effect on the rates of implantation, pregnancy, live delivery, and early pregnancy loss during in vitro fertilization (IVF). The effectiveness of radiological tubal blockage has not been compared with the standard treatment of laparoscopic salpingectomy in randomized trials. The investigators aim in this randomized trial to compare the live birth rate of radiological tubal blockage versus laparoscopic salpingectomy in infertility women with HX prior to frozen-thawed embryo transfer (FET). Eligible women will be recruited and randomized into one of the following two groups: (1) the radiological tubal blockage group and (2) the laparoscopic salpingectomy group. The primary outcome is the live birth rate.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03521128
Study type Interventional
Source ShangHai Ji Ai Genetics & IVF Institute
Contact
Status Withdrawn
Phase N/A
Start date May 5, 2018
Completion date July 2029

See also
  Status Clinical Trial Phase
Recruiting NCT02977234 - Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx Phase 1/Phase 2
Completed NCT03854292 - Hydrosalpinx Management Before Intracytoplasmic Sperm Injection
Completed NCT03703401 - The Role of Hydrosalpinx in Recurrent Miscarriage
Completed NCT04071574 - Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Phase 1/Phase 2
Recruiting NCT03395301 - Coil Hysteroscopic Tubal Occlusion in the Treatment of Hydrosalpinx N/A
Completed NCT05195073 - Three Dimensional Versus Two Dimensional Laparoscopic Salpingectomy in Patients With Hydrosalpinx Undergoing IVF-ET N/A
Completed NCT04335864 - Comparing the Impact of 2 Different Techniques in Management of Hydrosalpinx on Pregnancy Rates Following ICSI N/A